Tscan Therapeutics Share Price (NASDAQ: TCRX)
$1.8
Last updated on
Check the interactive Tscan Therapeutics Stock chart to analyse performance
Tscan Therapeutics stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$1.80Today's High:$1.82
0.0%
Downside
Day's Volatility :1.1%
Upside
1.1%
- 52 Weeks Low:$1.0252 Weeks High:$6.23
43.33%
Downside
52 Weeks Volatility :83.61%
Upside
71.08%
Tscan Therapeutics Stock Returns
Tscan Therapeutics Inc Key Stats
Check Tscan Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Tscan Therapeutics Stock including INR - Dollar returns
The Tscan Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Tscan Therapeutics investment value today
Current value as on today
₹38,679
Returns
Returns from Tscan Therapeutics Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Tscan Therapeutics Stock
Global Institutional Holdings in Tscan Therapeutics Inc
Name
Holdings %
Bvf Inc
9.21%
BlackRock Inc
8.60%
Adage Capital Partners Gp LLC
6.17%
Baker Bros Advisors LP
4.91%
Vanguard Group Inc
3.79%
Propel Bio Management LLC
3.68%
Analyst Recommendation on Tscan Therapeutics Stock
Buy
91%Buy
8%Hold
0%Sell
Based on 12 Wall street analysts offering stock ratings for Tscan Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Tscan Therapeutics Share Price Target
What analysts predicted
Upside of 376.19%
Target:
$8.57
Current:
$1.80
Tscan Therapeutics share price target is $8.57, a slight Upside of 376.19% compared to current price of $1.80 as per analysts' prediction.
Tscan Therapeutics Stock Insights
Price Movement
In the last 1 year, TCRX stock has moved down by -68.0%Increasing Revenue
Revenue is up for the last 3 quarters, 665.0K → 3.07M (in $), with an average increase of 49.4% per quarterDecreasing Net Profit
Netprofit is down for the last 2 quarters, -34.12M → -36.95M (in $), with an average decrease of 8.3% per quarterTCRX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 137.9%TCRX vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 148.3%Price to Sales
ForTCRX every $1 of sales, investors are willing to pay $14.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Tscan Therapeutics Technicals Summary
Sell
Neutral
Buy
Tscan Therapeutics is currently in a neutral trading position according to technical analysis indicators.
Tscan Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 11.11% | -2.44% | -66.6% | -35.94% | -82.86% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -1.25 | -0.63 | -0.27 | NA | 3.11 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $106.1M | -82.86% | NA | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Tscan Therapeutics Inc
Key Management of Tscan Therapeutics Inc
Important FAQs about investing in TCRX Stock from India :
What is Tscan Therapeutics share price today?
Tscan Therapeutics share price today is $1.80 as on at the close of the market. Tscan Therapeutics share today touched a day high of $1.82 and a low of $1.80.
What is the 52 week high and 52 week low for Tscan Therapeutics share?
Tscan Therapeutics share touched a 52 week high of $6.23 and a 52 week low of $1.02. Tscan Therapeutics stock price today i.e. is closed at $1.80, lower by 71.08% versus the 52 week high.
How to invest in Tscan Therapeutics Stock (TCRX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Tscan Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tscan Therapeutics Shares that will get you 0.8333 shares as per Tscan Therapeutics share price of $1.80 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Tscan Therapeutics Stock (TCRX) from India?
Indian investors can start investing in Tscan Therapeutics (TCRX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Tscan Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Tscan Therapeutics share’s latest price of $1.80 as on August 30, 2025 at 1:29 am IST, you will get 5.5556 shares of Tscan Therapeutics. Learn more about
fractional shares .
What are the returns that Tscan Therapeutics has given to Indian investors in the last 5 years?
Tscan Therapeutics stock has given -82.86% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
- Cambria Value And Momentum Etf
$32.55
+0.25%